Ligand
also invests · investor profile1 known investors
Ligand is a royalty aggregator that finances late-stage clinical development and commercialization programs for biopharmaceutical companies. The company maintains a diversified portfolio of royalty assets across oncology, rare diseases, and other therapeutic areas, and licenses proprietary technology platforms to pharmaceutical manufacturers.
Founders & leadership
TD
Todd DavisinChief Executive Officer
Investors · 1
Acquisitions · 1
Early investors' stakes continue via these dealsXOMA Royalty
Biopharma royalty company acquired by Ligand, adding seven commercial products and more than 100 additional programs.
In the news
Frequently asked questions
- What does Ligand do?
- Ligand is a royalty aggregator that finances late-stage clinical development and commercialization programs for biopharmaceutical companies. The company maintains a diversified portfolio of royalty assets across oncology, rare diseases, and other therapeutic areas, and licenses proprietary technology platforms to pharmaceutical manufacturers.
- Who are Ligand's investors?
- Ligand's investors include Signet Healthcare Partners.